Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315) Stock Catapults 32% Though Its Price And Business Still Lag The Industry
The Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315) share price has done very well over the last month, posting an excellent gain of 32%. This latest share price bounce rounds out a remarkable 372% gain over the last twelve months.
In spite of the firm bounce in price, Biocytogen Pharmaceuticals (Beijing) may still be sending bullish signals at the moment with its price-to-sales (or “P/S”) ratio of 9.1x, since almost half of all companies in the Biotechs industry in Hong Kong have P/S ratios greater than 17.4x and even P/S higher than 58x are not unusual. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the reduced P/S.
